Baicalein inhibits progression of gallbladder cancer cells by downregulating ZFX

PLoS One. 2015 Jan 24;10(1):e0114851. doi: 10.1371/journal.pone.0114851. eCollection 2015.

Abstract

Baicalein, a widely used Chinese herbal medicine, has multiple pharmacological activities. However, the precise mechanisms of the anti-proliferation and anti-metastatic effects of baicalein on gallbladder cancer (GBC) remain poorly understood. Therefore, the aim of this study was to assess the anti-proliferation and anti-metastatic effects of baicalein and the related mechanism(s) on GBC. In the present study, we found that treatment with baicalein induced a significant inhibitory effect on proliferation and promoted apoptosis in GBC-SD and SGC996 cells, two widely used gallbladder cancer cell lines. Additionally, treatment with baicalein inhibited the metastasis of GBC cells. Moreover, we demonstrated for the first time that baicalein inhibited GBC cell growth and metastasis via down-regulation of the expression level of Zinc finger protein X-linked (ZFX). In conclusion, our studies suggest that baicalein may be a potential phytochemical flavonoid for therapeutics of GBC and ZFX may serve as a molecular marker or predictive target for GBC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Carcinoma / drug therapy
  • Carcinoma / pathology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Down-Regulation*
  • Drugs, Chinese Herbal / pharmacology*
  • Flavanones / chemistry
  • Flavanones / pharmacology*
  • Gallbladder Neoplasms / drug therapy
  • Gallbladder Neoplasms / pathology*
  • Humans
  • Kruppel-Like Transcription Factors / genetics*
  • Male
  • Mice, Nude
  • Neoplasm Metastasis / prevention & control
  • Xenograft Model Antitumor Assays

Substances

  • Drugs, Chinese Herbal
  • Flavanones
  • Kruppel-Like Transcription Factors
  • zinc finger protein, X-linked
  • baicalein

Grants and funding

This study was supported by National Natural Science Foundation of China (No. 81172026, 81272402, 81301816 and 81172029), National High Technology Research and Development Program (863 Program) (No. 2012AA022606), Foundation for Interdisciplinary research of Shanghai Jiao Tong University (No. YG2011ZD07), Shanghai science and technology commission inter-governmental international cooperation project (No. 12410705900), Shanghai science and technology commission medical-guiding project (No. 12401905800), Program for Changjiang Scholars, Natural Science Research Foundation of Shanghai Jiao Tong University School of Medicine (No. 13XJ10037), Leading Talent program of Shanghai, Sailing program of Shanghai science and technology commission (14YF1403000) and Specialized Research Foundation for Ph.D Program of Higher Education-Priority Development Field (No. 20130073130014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.